These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7899741)
21. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna. Armbruster C; Kriwanek S; Vorbach H Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904 [TBL] [Abstract][Full Text] [Related]
23. [Preliminary report on the effect of low doses of azidothymidine (AZT) in the treatment of patients with stage III infection by human immunodeficiency virus (HIV)]. Lobato-Mendizábal E; Ruiz-Argüelles GJ; García-Gallardo E; Marín-López A; Marín-López E Rev Invest Clin; 1990; 42(2):88-92. PubMed ID: 1980026 [TBL] [Abstract][Full Text] [Related]
24. A randomized trial of reduced doses of azidothymidine in Japanese patients with human immunodeficiency virus type 1 infection. Kimura S; Oka S; Toyoshima T; Hirabayashi Y; Kikuchi Y; Mitamura K; Shimada K Intern Med; 1992 Jul; 31(7):871-6. PubMed ID: 1360277 [TBL] [Abstract][Full Text] [Related]
25. [Administer zidovudine early or late?]. Diener HC Med Monatsschr Pharm; 1992 Aug; 15(8):243. PubMed ID: 1508068 [No Abstract] [Full Text] [Related]
26. Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop. Richman DD; Havlir D Drugs; 1995; 49 Suppl 1():9-16; discussion 38-40. PubMed ID: 7614902 [TBL] [Abstract][Full Text] [Related]
27. Should the dosage of zidovudine be adjusted in HIV-infected patients with impaired renal function? Amantea MA Am J Hosp Pharm; 1990 Mar; 47(3):618-9. PubMed ID: 2316548 [No Abstract] [Full Text] [Related]
28. Zidovudine dosage. Nordic Medical Research Councils' HIV Therapy Group. Gøtzsche P BMJ; 1993 Sep; 307(6905):682-3. PubMed ID: 8292147 [No Abstract] [Full Text] [Related]
29. Does the classification system fit disease progression in perinatal human immunodeficiency virus infection? de Martino M; Zappa M; Galli L; Rossi ME; Vierucci A Acta Paediatr; 1996 Jun; 85(6):724-7. PubMed ID: 8816212 [TBL] [Abstract][Full Text] [Related]
30. Concorde trial of immediate versus deferred zidovudine. Montaner JS; Raboud J; O'Shaughnessy M Lancet; 1994 May; 343(8909):1356-7; author reply 1358. PubMed ID: 7910337 [No Abstract] [Full Text] [Related]
31. MAB labelled liposomes as selective vehicles for drugs in H.I.V. infected cells. Rombi G; Piu G; Piro S; Anedda V Cytotechnology; 1993; 11 Suppl 1():S147-9. PubMed ID: 7763746 [No Abstract] [Full Text] [Related]
34. Re: "Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts". Vanhems P; Allard R Am J Epidemiol; 1995 Apr; 141(8):788-9. PubMed ID: 7709923 [No Abstract] [Full Text] [Related]
35. [Life expectancy of patients with human immunodeficiency virus infection with CD4 lymphocytes below or equal to 50 microliter. Retrospective study with 91 treated patients]. Nasica O; Partisani M; Rey D; Jacquemin C; Roos M; Lang JM Presse Med; 1996 May 4-11; 25(16):775-6. PubMed ID: 8692756 [No Abstract] [Full Text] [Related]
37. Can we predict the prognosis of HIV infection? How to use the findings of a prospective study. Low N; Egger M Sex Transm Infect; 1998 Apr; 74(2):149-54. PubMed ID: 9634332 [No Abstract] [Full Text] [Related]
38. The influence of rutin on the weight, metastasis and melanin content of B16 melanotic melanoma in C57BL/6 mice. Drewa G; Schachtschabel DO; Pałgan K; Grzanka A; Sujkowska R Neoplasma; 1998; 45(4):266-71. PubMed ID: 9890672 [TBL] [Abstract][Full Text] [Related]
39. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists. Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851 [TBL] [Abstract][Full Text] [Related]